Rujun Mo

703 citations

21 papers · 454 indexed · h-index 13

Impact in

Cancer Research
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
Oncology

Papers in ⓘ

Cancer Research 5
- Cancer, Hypoxia, and Metabolism 4
- Cancer, Lipids, and Metabolism 2
Pulmonary and Respiratory Medicine 10
- Prostate Cancer Treatment and Research 9

Co-authors: Weide Zhong (18 shared papers)Huichan He (12 shared papers)Funeng Jiang (7 shared papers)Zhaodong Han (9 shared papers)Yongding Wu (5 shared papers)Jianguo Zhu (5 shared papers)Yangjia Zhuo (6 shared papers)Yuxiang Liang (6 shared papers)
Journals: Disease Markers (2 papers)Clinical & Translational Oncology (1 paper)Global Ecology and Conservation (1 paper)International Journal of Biological Macromolecules (1 paper)Frontiers in Cell and Developmental Biology (1 paper)
Partner nations: China United States Japan

In The Last Decade

Rujun Mo

21 papers receiving 450 citations

Peers

Countries citing papers authored by Rujun Mo

Since Specialization

Citations

This map shows the geographic impact of Rujun Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rujun Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rujun Mo more than expected).

Fields of papers citing papers by Rujun Mo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rujun Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rujun Mo. The network helps show where Rujun Mo may publish in the future.

Co-authors

The 25 scholars most cited alongside Rujun Mo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rujun Mo Line = papers co-authored together Rujun Mo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	GPD1 Enhances the Anticancer Effects of Metformin by Synergistically Increasing Total Cellular Glycerol-3-Phosphate Cancer Research ·Jianjiang Xie, Jian‐Heng Ye, Zhiduan Cai, Yong Luo, Xuejin Zhu, Yulin Deng, Yuanfa Feng, Yingke Liang, Ren Liu, Zhaodong Han, Yuxiang Liang, Yu Zheng, Rujun Mo, Yangjia Zhuo, Yongding Wu, Funeng Jiang, Jianguo Zhu, Chin‐Lee Wu, Weide Zhong	2020	51
2	E2F1 promotes tumor cell invasion and migration through regulating CD147 in prostate cancer International Journal of Oncology ·Yuxiang Liang, Jianming Lü, Rujun Mo, Huichan He, Jian Xie, Funeng Jiang, Zhuoyuan Lin, Yanru Chen, Yongding Wu, Hongwei Luo, Zheng Luo, Weide Zhong	2016	47
3	Expression of PD‐L1 in tumor‐associated nerves correlates with reduced CD8⁺ tumor‐associated lymphocytes and poor prognosis in prostate cancer International Journal of Cancer ·Rujun Mo, Zhaodong Han, Yingke Liang, Jian‐Heng Ye, Shulin Wu, Sharron X. Lin, Yanqiong Zhang, Shengda Song, Funeng Jiang, Weide Zhong, Chin‐Lee Wu	2018	44
4	High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer International Urology and Nephrology ·Jianjiang Xie, Yangjia Zhuo, Yu Zheng, Rujun Mo, Zezhen Liu, Bowei Li, Zhiduan Cai, Xuejin Zhu, Yuxiang Liang, Huichan He, Weide Zhong	2017	41
5	Expression of SOCSs in human prostate cancer and their association in prognosis Molecular and Cellular Biochemistry ·Jianguo Zhu, Qi-Shan Dai, Zhaodong Han, Huichan He, Rujun Mo, Guo Chen, Yanfei Chen, Yongding Wu, Sheng-Bang Yang, Funeng Jiang, Weihong Chen, Zhaolin Sun, Weide Zhong	2013	41
6	CC Chemokine Ligand 18 Correlates with Malignant Progression of Prostate Cancer BioMed Research International ·Guo Chen, Yuxiang Liang, Jianguo Zhu, Xin Fu, Yanfei Chen, Rujun Mo, Liang Zhou, Hao Fu, Xue‐cheng Bi, Huichan He, Sheng-Bang Yang, Yongding Wu, Funeng Jiang, Weide Zhong	2014	41
7	Autophagy induced by overexpression of DCTPP1 promotes tumor progression and predicts poor clinical outcome in prostate cancer International Journal of Biological Macromolecules ·Jianming Lü, Weimin Dong, Huichan He, Zhaodong Han, Yangjia Zhuo, Rujun Mo, Yingke Liang, Jianguo Zhu, Ruidong Li, Han Qu, Le Zhang, Shibo Wang, Renyuan Ma, Zhenyu Jia, Weide Zhong	2018	32
8	Enhanced expression of IMPDH2 promotes metastasis and advanced tumor progression in patients with prostate cancer Clinical & Translational Oncology ·Lizhi Zhou, Dan Xia, Jian Zhu, Yun-Xia Chen, G. Chen, Rujun Mo, Yue Zeng, Qing-Qing Dai, Hua He, Yingying Liang, Fan Jiang, Weide Zhong	2014	26
9	An Integrative Proteomics and Interaction Network-Based Classifier for Prostate Cancer Diagnosis PLoS ONE ·Funeng Jiang, Huichan He, Yanqiong Zhang, Deng-Liang Yang, Jiehong Huang, Yunxin Zhu, Rujun Mo, Guo Chen, Sheng-Bang Yang, Yanru Chen, Weide Zhong, Wen‐Liang Zhou	2013	25
10	TRIB1 induces macrophages to M2 phenotype by inhibiting IKB-zeta in prostate cancer Cellular Signalling ·Zezhen Liu, Zhaodong Han, Yingke Liang, Junxu Chen, Wan Song, Yangjia Zhuo, Zhiduan Cai, Yulin Deng, Zhuoyuan Lin, Rujun Mo, Huichan He, Weide Zhong	2019	25
11	Expression and Clinical Significance of SOX9 in Renal Cell Carcinoma, Bladder Cancer and Penile Cancer Oncology Research and Treatment ·Yueping Wan, Ming Xi, Huichan He, Wan Song, Wei Hua, Zhao-Chang Zen, Yuanling Liu, Yulin Zhou, Rujun Mo, Yangjia Zhuo, Hongwei Luo, Funeng Jiang, Weide Zhong	2017	20
12	Down-regulation of the ErbB3 binding protein 1 in human bladder cancer promotes tumor progression and cell proliferation Molecular Biology Reports ·Huichan He, Xiaohui Ling, Jianguo Zhu, Xin Fu, Zhaodong Han, Yu-xian Liang, Ye-han Deng, Zhuoyuan Lin, Guo Chen, Yanfei Chen, Rujun Mo, Weide Zhong	2013	15
13	Differential Expression of E2F Transcription Factors and Their Functional and Prognostic Roles in Human Prostate Cancer Frontiers in Cell and Developmental Biology ·Zhaodong Han, Rujun Mo, Shanghua Cai, Yuanfa Feng, Zhenfeng Tang, Jian‐Heng Ye, Ren Liu, Zhiduan Cai, Xuejin Zhu, Yulin Deng, Zhihao Zou, Yongding Wu, Zhouda Cai, Yuxiang Liang, Weide Zhong	2022	14
14	ARNT‐dependent CCR8 reprogrammed LDH isoform expression correlates with poor clinical outcomes of prostate cancer Molecular Carcinogenesis ·Guo Chen, Zhiduan Cai, Zhuoyuan Lin, Cong Wang, Yuxiang Liang, Zhaodong Han, Huichan He, Rujun Mo, Jian‐ming Lu, Bin Pan, Chin‐Lee Wu, Fen Wang, Weide Zhong	2020	12
15	Aberrant hypomethylation-mediated CD147 overexpression promotes aggressive tumor progression in human prostate cancer Oncology Reports ·Yuxiang Liang, Rujun Mo, Huichan He, Jiahong Chen, Jun Zou, Zhaodong Han, Jianming Lü, Chao Cai, Yanru Zeng, Weide Zhong, Chin‐Lee Wu	2015	7
16	Tumor Suppressor Role and Clinical Significance of the FEV Gene in Prostate Cancer Disease Markers ·Yuxiang Liang, Yingke Liang, Zhihao Zou, Yangjia Zhuo, Jian-Heng Ye, Xuejin Zhu, Zhouda Cai, Zhuoyuan Lin, Rujun Mo, Shulin Wu, Yanqiong Zhang, Weide Zhong	2022	4
17	Chromosome-scale assembly and analysis of yellow Camellia (Camellia limonia) genome reveal plant adaptation mechanism and flavonoid biosynthesis in karst region Global Ecology and Conservation ·Yingying Lu, H. Liang, Jialin Liao, Xianglong Li, Youmin Rong, Rujun Mo, Jianmin Tang, Maoteng Li, Xiangdong Kong, Yang Huang, Yu Liang	2024	2
18	GG-NER’s role in androgen receptor signaling inhibitor response for advanced prostate cancer Cell Communication and Signaling ·Chuanfan Zhong, J X Wang, H L Peng, Jianming Lü, Zining Long, Zhuoyuan Lin, Guo Chen, Chao Cai, Shilong Cheng, Zhongjie Chen, Le Zhang, Weibo Zhong, Rujun Mo, Xiangming Mao	2024	2
19	Development and validation of a kinase-related gene signature as a novel diagnostic and prognostic model for prostate cancer Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Yaqiang Huang, Haiying Zhu, Zhenguo Liang, Weiyang Wei, Hao Yang, Qi Wang, Hongxing Huang, Huichan He, Rujun Mo, Jianheng Ye, Qi-Shan Dai, Weide Zhong, Yingke Liang	2025	2
20	Identification and Validation of FGF-Related Prognostic Signatures in Prostate Cancer Disease Markers ·Yongkang Ye, Rujun Mo, Ruinian Zheng, Jun Zou, Shaoqian Liu, Qiwu Mi, Weide Zhong	2023	2

About Rujun Mo

Rujun Mo is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Cell Biology, Oncology and Molecular Biology, having authored 21 papers that have together received 454 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (9 papers), Cancer, Hypoxia, and Metabolism (4 papers), Cancer-related gene regulation (4 papers), Epigenetics and DNA Methylation (3 papers), RNA modifications and cancer (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (147 citations), Oncology (115 citations), Molecular Biology (282 citations), Pulmonary and Respiratory Medicine (120 citations) and Immunology (67 citations). Rujun Mo has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Weide Zhong, Huichan He, Funeng Jiang, Zhaodong Han, Yongding Wu, Jianguo Zhu, Yangjia Zhuo, Yuxiang Liang, Yingke Liang and Zhiduan Cai. Their work appears in journals such as Disease Markers, Clinical & Translational Oncology, Global Ecology and Conservation, International Journal of Biological Macromolecules and Frontiers in Cell and Developmental Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact